These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7022885)

  • 1. Prolongation of mouse heart allograft survival by prior administration of nonspecific blood.
    Kelley SE; Corry RJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):518-22. PubMed ID: 7022885
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of blood transfusion and cyclophosphamide on cardiac allograft survival in sensitized mice.
    Lasek W; Sora M; Jakóbisiak M
    Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):399-403. PubMed ID: 8572899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is recipient priming with graft foreign antigen a prerequisite for the blood transfusion effect?
    Corry RJ; Shelby J; David C; Heffner C; Billingsley A; Kelley SE
    Transplant Proc; 1982 Jun; 14(2):391-3. PubMed ID: 6180531
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple nonspecific blood transfusions prolong skin allograft survival in immunosuppressed mice.
    Okazaki H; Maki T; Monaco AP
    Proc Clin Dial Transplant Forum; 1979; 9():230-3. PubMed ID: 399513
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic requirement for induced rejection of long-surviving murine heart transplants.
    Burdick JF; Russell PS
    J Immunol; 1982 Apr; 128(4):1551-4. PubMed ID: 7037951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH; Milekhin V; Zhang H; Huang HZ
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of rat cardiac allograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Jin YT; Lee PH; Lee CJ
    Transplant Proc; 1994 Aug; 26(4):2323-6. PubMed ID: 8066761
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice.
    Bergese SD; Pelletier RP; Ferguson RM; Orosz CG
    Transplant Proc; 1995 Feb; 27(1):480-1. PubMed ID: 7533417
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of hamster-to-rat cardiac xenograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Hung CJ; Arakawa K; Oka T
    Transplant Proc; 1996 Jun; 28(3):1397-9. PubMed ID: 8658711
    [No Abstract]   [Full Text] [Related]  

  • 17. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac allograft rejection in the absence of macrophage migration inhibitory factor.
    Demir Y; Chen Y; Metz C; Renz H; Heeger PS
    Transplantation; 2003 Jul; 76(1):244-7. PubMed ID: 12865817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice.
    Barrett LV; Rimm IJ; Wiens GR; Seidman JG; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):366-7. PubMed ID: 8438338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.